Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team

You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?

Scanfil Q4 & CMD: Inside sells not worrying

Scanfil

Head of Research Antti Viljakainen summarizes Scanfil’s Q4’23 and recent CMD: raised bar regarding growth going forward, inside sells and polarized growth is not worrying, still upside potential in the stock.

Read the latest research: Scanfil: Light sigh of relief with guidance, published 2024-02-26 

Content:
00:00 Intro
00:10 Polarized growth
01:39 Top picks from CMD
04:28 Inside sales
05:36 Recommendation

Read more about Scanfil!

We also recommend the following videos:
Contract Manufacturers 
Incap vs Scanfil: to Buy or not to buy
Scanfil Q3'23: No surprises

Stay up to date
Analyst Interviews

Recent videos

AKTIER MED FRIIS - UGE 50 2025
12.12.2025, 12.00
HCA Morgenbørs 12/12 - Positive futures og fokus på FLSmidth og fedme aktier
12.12.2025, 09.27 Novo Nordisk
A sit-down with CEO Remco Westermann
12.12.2025, 09.09 Verve Group
Aiforia as an Investment | Life Science Night Dec 9, 2025
11.12.2025, 11.00 Aiforia Technologies
HCA Morgenbørs 11/12 - Flade europæiske futures, Oracle skaber usikkerhed om AI
11.12.2025, 09.45 GreenMobility
View all videos
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.